title: Drug treatment for melanoma: progress, but who pays? Comment.
authors.forename: Richard F
authors.initials: RF
authors.lastname: Kefford
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016527:Drug Costs; D005380:Financing, Government; D006291:Health Policy / Q000191:economics*; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008545:Melanoma / Q000188:drug therapy*; D013449:Sulfonamides / Q000627:therapeutic use*
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D007211:Indoles; D013449:Sulfonamides